News and events

16-07-2019
Cutaneous leishmaniasis (CL) is a poverty related, neglected tropical disease, which is without an effective and cheap systemic treatment. The aim of TT4CL is to develop a new orally available drug for treatment of CL aimed towards registration ...
Read More
15-07-2019
TT4CL (Targeted treatment for cutaneous leishmaniasis) is a new Horizon 2020-funded project which aims to reduce the burden of a Neglected Infectious (NID) and its social and economic impacts. Horizon 2020, the European Union’s (EU) research ...
Read More
04-07-2019
Today we were delighted to welcome specialists from across the world to @StGeorgesUni to the TT4CL kick-off meeting. It has been an honour to host this event and we look forward to developing a new Leishmaniasis drug
Read More
01-05-2019
We are delighted to announce that the grant agreement no. 815622 between the European Commission and 5 European partners and 1 Iranaian partner hes been signed on May 1, 2019. The name of the project is TT4CL, “targeted treatment for...
Read More

Subscribe to our newsletter